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Abstract
Objective—This study expands previous equine-assisted intervention research by evaluating the 
effectiveness of therapeutic horseback riding (THR) on self-regulation, socialization, 
communication, adaptive, and motor behaviors in children with autism spectrum disorder (ASD).
Method—Participants with ASD (ages 6–16 years; N=127) were stratified by nonverbal IQ 
standard scores (≤ 85 or > 85) and randomized to one of two groups for 10 weeks: THR 
intervention or a barn activity (BA) control group without horses that employed similar methods. 
The fidelity of the THR intervention was monitored. Participants were evaluated within one month 
pre- and post-intervention by raters blind to intervention conditions and unblinded caregiver 
questionnaires. During the intervention, caregivers rated participants’ behaviors weekly.
Results—Intent-to-treat analysis conducted on the 116 participants who completed a baseline 
assessment (THR n = 58; BA control n = 58) revealed significant improvements in the THR group 
compared to the control on measures of irritability (primary outcome) (p=.002; effect size [ES]=.
50) and hyperactivity (p=.001; ES=0.53), beginning by week five of the intervention. Significant 
improvements in the THR group were also observed on a measure of social cognition (p=.05, ES=.
41) and social communication (p=.003; ES =.63), along with the total number of words (p=.01; 
ES=.54) and new words (p=.01; ES=.54) spoken during a standardized language sample. 
Sensitivity analyses adjusting for age, IQ, and per-protocol analyses produced consistent results.
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Conclusion—This is the first large-scale randomized, controlled trial demonstrating efficacy of 
THR for the ASD population, and findings are consistent with previous equine-assisted 
intervention studies.
Clinical trial registration information—Trial of Therapeutic Horseback Riding in Children 
and Adolescents With Autism Spectrum Disorder; http://clinicaltrials.gov/; NCT02301195.
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Autism spectrum disorder; equine-assisted activities and therapies; human-animal interaction; 
therapeutic horseback riding; social-communication functioning
INTRODUCTION
Autism spectrum disorder (ASD) is a neurodevelopmental disorder diagnosed based on core 
impairments in social interaction, communication abilities, and the presence of restricted, 
repetitive, and stereotyped behaviors and interests.1 Although these core impairments have a 
heterogeneous clinical presentation across individuals with ASD, limited joint attention 
skills (i.e., being aware of and sharing another’s focus of attention) appear to be an 
important issue underlying social-communication symptoms.2 Improving joint attention 
skills in the ASD population has been linked to better behavioral regulation, communication 
skills, and social competence.3
Children with ASD exhibit more challenging or inappropriate behaviors than typically 
developing peers or those diagnosed with other psychopathology.4–6 The ASD population 
has high incidences of stress, anxiety, and depression,7,8 along with a variety of other 
challenges such as irritability, hyperactivity, and problems with sensory processing, 
dyspraxia, intellectual functioning, adaptive daily living skills, and sleep.9–11 Co-occurrence 
of these issues with core ASD symptoms can present challenging behaviors, often persisting 
beyond childhood into adolescence and adulthood.12 Research indicates that care and 
management of these challenging behaviors contributes to higher rates of stress and greater 
burden among caregivers of individuals with ASD compared with other special needs 
populations.13–15
Incorporating animals into the treatment process to decrease problem behaviors and improve 
functioning has been proposed as a promising area of intervention for these at-risk 
populations.16 Evidence for animal-assisted interventions (AAI) is limited; however, 
including animals in health care settings has been hypothesized to produce sensory-related 
relaxation experiences that allow children to better manage stressful events and engage in 
prosocial behaviors17. Studies have cited reductions in stress hormone levels (i.e. cortisol) in 
children with ASD following interactions with service dogs, and also in a general child 
population following an 11-week equine intervention.18, 19 The ASD population has a 
particular need for interventions that target reductions in stress-related maladaptive 
behaviors and improvements in social-communication functioning.
O’Haire’s (2013) comprehensive review of AAIs targeting individuals with ASD identified 
only 14 empirically-based studies from 1840 to 2011, with interventions that intentionally 
Gabriels et al. Page 2













included a live animal, and reported results. In those studies, results indicated improvements 
in social interaction communication skills, behaviors, and stress levels, even though 
intervention methods and types of animals varied (i.e., dogs, guinea pigs, lamas, rabbits, 
horses). O’Haire (2013) recommended future AAI studies increase methodological rigor by 
randomizing participants to comparison treatments without animals, employing outcome 
raters blind to intervention conditions, and replicating methods.20
One form of AAI includes Equine-Assisted Activities and Therapies (EAAT). This is a 
rapidly growing field for special needs populations that involves horses in a therapeutic 
intervention setting. Since 2009, there has been an increase in EAAT publications citing 
various methods for working with the ASD population, including therapeutic horseback 
riding (THR),21–24 hippotherapy (HPOT),25,26 psychoeducational horseback riding (PER),27 
and EAAT.28, 29 Although each method offers a different therapeutic focus and type of 
activity, the inclusion of horses as part of the therapeutic experience is a common thread. 
THR typically involves riding in small group settings led by a certified THR instructor 
teaching horsemanship skills targeting therapeutic goals.30 Hippotherapy is led by an 
occupational, speech, or physical therapist, and intervention activities use the movement of 
the horse to target functional outcomes.31
Though EAAT methods vary, cited improvements with the ASD population overlap across 
studies, suggesting that some aspect(s) of the human-equine interaction may be important 
for change. Temple Grandin, an accomplished adult with ASD, asserts that one key element 
of horseback riding that helped her decrease anxiety-related feelings and behaviors involves 
the reciprocal/joint attention relationship, or “teamwork,” between the rider and the horse 
(e.g., moving “in sync with the horse’s body” and the horse’s intuitive sensitivity and 
responsiveness to the rider) (p. 6).32 Despite EAAT study variations (i.e., duration, 
activities, and targeted outcome measures), results include decreases in problem behaviors 
(e.g., irritability, hyperactivity, stereotypy, inattention, self-injury, and ASD symptom 
severity)21–23,26,28 as well as increases in sensory processing,21, 28, 29 
communication,22, 23, 25, 27, 29 and social skills.21, 27–29 Although these EAAT studies offer 
promising preliminary effects for individuals with ASD, generalizability of these findings 
are limited by small sample sizes, minimal methods to confirm the ASD diagnosis, and use 
of potentially biased informants for outcome measures.
The present study builds upon the piloted22 10-week THR intervention curriculum 
conducted by the authors and available from the first author. The objective of this RCT was 
to evaluate whether the THR could affect significant improvements on measures of self-
regulation, communication, social, adaptive, and motor behaviors in children and 
adolescents diagnosed with ASD. The second, exploratory, aim to evaluate the retention of 
improvements six months following the THR intervention phase will be reported separately. 
This study has an elevated level of methodological rigor (i.e., randomized controlled design, 
use of a well-established standardized ASD diagnostic measure, control group without 
horses that mirrored THR intervention methods, fidelity measure of the THR intervention, 
and outcome evaluators blind to participants’ intervention condition), and was conducted at 
an established (30 years) riding center site with “premiere” certification by PATH 
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International,30 meaning the center adheres to the highest safety and ethical standards in the 
industry for all living beings involved in the treatment process.
METHOD
Participants
This study was approved by the Institutional Review Board (IRB) at the first author’s 
institution. Participants were recruited using IRB-approved fliers distributed to university-
affiliated hospitals, schools, ASD parent support organizations, and community providers. 
Participants’ caregivers were compensated for mileage to study visits.
Participants were included in the study if they met the following criteria: aged 6 to 16 years; 
met or exceeded the ASD screening cut-off (≥ 15) on the Social Communication 
Questionnaire (SCQ);33 had an ASD diagnosis, confirmed by meeting clinical cut-offs for 
ASD on the Autism Diagnostic Observation Schedule (ADOS) or ADOS-second edition 
(ADOS-2);34, 35 had a combined score on the Irritability and Stereotypy subscales of the 
Aberrant Behavior Checklist-Community (ABC-C)36 of ≥ 11 and had a Leiter-R37 Brief 
nonverbal IQ (NVIQ) standard score of ≥ 40, as established by the pilot.22 Exclusion criteria 
included: a previously identified genetic disorder known to be causative of or resulting in a 
phenotype similar to ASD, a history of medical or behavioral issues making participation 
dangerous, a history of animal abuse or phobia of horses, more than two hours of EAAT 
within the past six months, or weight exceeding the riding center’s policies to ensure the 
health and safety of staff and volunteers. In cases with more than one child with ASD in a 
family, only the first sibling who qualified for the study was included to avoid duplication of 
caregiver reporting styles. See Figure 1 for the participant flowchart.
Study Design
Screening—Participants were scheduled for an initial study diagnostic and NVIQ 
assessment visit at the first author’s institution, during which informed consent from each 
participant’s legal guardian was obtained. If the participant was seven or older, verbal, and 
had an IQ ≥ 80, informed assent was obtained (and child’s wishes were not overridden).
Randomization—Eligible participants were randomized into one of two groups (THR or 
BA). Random group assignment study numbers were generated by the statistician on this 
project using a size-four block randomization stratified by NVIQ (≤ 85 or > 85) to ensure 
that this factor was comparable between groups. Participants randomized to the barn activity 
(BA) control group were offered two free riding lessons at study conclusion.
Riding Center Screening—After physician and caregiver medical clearance forms were 
completed, participants were screened at the riding center by their assigned group leader. 
Study attendance and riding center policies were reviewed, and physical, behavioral, and 
adaptive functioning levels were observed in order to assign groups similar in age and/or 
ability. THR group participants were fitted for a helmet and mounted a horse for 10 minutes 
while they engaged in a consistent sequence of activities (i.e., hold reins, asking the horse to 
“walk on” and “whoa,” stretching exercises, brief seated trot) with the assistance of one 
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volunteer who led the horse and up to two volunteers who walked beside the horse. BA 
control group participants completed a brief art project.
Interventions
Both 10-week interventions were a minimum of 45 minutes long each session, had two to 
four participants, had equine-related information content, assigned at least one volunteer to 
each participant, and used behavioral teaching methods commonly used for the ASD 
population (e.g., use of visual aids, directly praising appropriate behaviors, and using the 
participant’s interest to engage).38 Every effort was made to maintain the consistency of 
horses for the THR group and volunteers for the THR and BA control groups.
Therapeutic Horseback Riding Intervention—A certified PATH International30 
advanced therapeutic riding instructor taught all lessons and followed the study manual 
approach that had a two-part teaching focus: 1) therapeutic riding skills (e.g., mounting, 
halting, steering, turning, and trotting) and 2) horsemanship skills (e.g., how to lead and care 
for their horse). Lessons followed a consistent routine presented as a picture schedule: 1) put 
on riding helmet, 2) wait on the bench, 3) mount horse, 4) riding activities, 5) dismount 
horse, 6) groom horse, and 7) put away equipment. The riding portion consisted of a warm 
up activity, skill review, learning a new skill, lesson review, and a cool down activity. After 
riding, participants led their horses to the tacking area where they learned and practiced un-
tacking and grooming skills, and thanked their horses and volunteers.
Barn Activity Control Intervention—The BA control groups were co-led by a THR 
instructor and a master’s level therapist who had expertise working with and modifying 
curriculums for children with ASD. Participants had no contact with horses; however, a life-
sized stuffed horse was an integral part of teaching horsemanship skills.
Fidelity—The essential components of the THR intervention groups were monitored by the 
principal investigator (PI) or co-investigator (Co-I) scoring 20% of the THR 10-week 
sessions on a four-point rating scale after they achieved at least 80% inter-reliability. The 
fidelity instrument targeted eight core areas covering environmental, volunteer, and 
instructor factors consistent with ASD learning needs.
Behavioral Outcome Measures
Within one month pre-and post-intervention, a battery of assessment measures were 
conducted to evaluate participants’ baseline and post-intervention functioning levels. A 
consistent caregiver not blinded to the intervention assignment for each participant 
completed all behavior rating forms before, during, and after the intervention phase. Study 
assessment personnel were blind to participants’ intervention assignment and did not have 
access to participants’ pre-intervention evaluations when conducting post- evaluations.
A speech therapist measured participants’ receptive vocabulary using the Peabody Picture 
Vocabulary Test, Fourth Edition (PPVT-4), norm-referenced and standardized for 
individuals ages 2 years, 6 months through age 90 years. 39 The PPVT-4 has two parallel 
forms: form A was used for pre-evaluations, and form B was used for post-evaluations. A 
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five-minute expressive language sample was elicited from participants using the Systematic 
Analysis of Language Transcripts (SALT)40, which provides guidelines for eliciting, 
transcribing, and analyzing language samples from individuals, including those with ASD. 
An occupational therapist administered the Bruininks-Oseretsky Test of Motor Proficiency–
2nd Ed (BOT-2)41 (Short Form) and two subscales of the Sensory Integration and Praxis 
Test (SIPT)42: Praxis on Verbal Command and Postural Praxis. Participants’ adaptive 
behaviors were evaluated by a study research assistant using the Vineland Adaptive 
Behavioral Scales – 2nd Edition, Survey Interview Form (VABS-II)43 with caregivers.
Caregivers rated participants’ irritability, lethargy/social withdrawal, stereotypy, 
hyperactivity, and inappropriate speech behaviors via the ABC-C36. The ABC-C is a 58-
item symptom checklist for assessing problem behaviors of children and adults with 
developmental disabilities in community settings.44, 45 Extensive psychometric assessment 
of the ABC-C indicates that its subscales have high internal consistency, adequate 
reliability, and established validity.44, 45 In addition, the ABC-C Irritability subscale is an 
established outcome measure in randomized clinical trials with the ASD population.46 
Caregivers also completed the Social Responsiveness Scale (SRS), which is a 65-item 
questionnaire that measures the social impairments in ASD on five subscales (Social 
Awareness, Social Cognition, Social Motivation, Social Communication and Autistic 
Mannerisms).47 The SRS has high internal consistency and retest temporal stability in males 
and females48 and was used in a previous THR study.21
Statistical Analyses
SAS 9.3 was used for all the analyses.49 Student t-tests and Chi square tests were used to 
compare the participants in the BA control group with the participants in THR intervention 
group for continuous and categorical demographic along with clinical and baseline outcome 
variables. The primary analyses used a linear mixed effects model (LMM) consisting of the 
baseline value and the post-evaluations as outcome measures, evaluation time (baseline or 
post-evaluation) of outcome, group (THR or BA), and their interaction tern as fixed effects 
and an unstructured covariance. Estimate of the interaction was used to assess the efficacy 
and test for statistical significance. The primary analysis included any randomized 
participants (n=116) who had either baseline and/or post-evaluation measure to follow the 
intent-to-treat (ITT) principle. No data imputation was taken. Sensitivity analysis was used 
in various ways to reanalyze the outcome found significant from the primary analyses to 
assess how robust the conclusions were. First, the efficacy was further tested while 
introducing age, IQ, and gender into the primary model as covariates even if there was no 
difference between the two groups in these covariates. Second, per-protocol analyses 
(including participants completing 80% or more of either intervention, n=100) were 
performed using the same method as the primary analysis. Finally a similar mixed effects 
model was used to fit the weekly ABC-C data to delineate the time course under which 
contrasts were used to test the between-group difference in the change from baseline by each 
week. The potential moderator effect of age, IQ, or gender was respectively examined by the 
same mixed effects model, with this factor and the three level interaction term of this fact, 
time, and group as two additional fixed effects. The fidelity of the THR treatment 
implementation was computed as a percentage of the eight intervention component ratings. 
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Irritability subscale of ABC-C was deemed as the primary outcome. No adjustment for 
multiple secondary outcome variables was applied.
Power of the Study
This study was primarily powered for efficacy tests to examine whether the THR 
intervention led to greater improvements on the ABC-C irritability subscale as compared to 
the BA control after the 10-week intervention. Taking into account active control group, the 
assumed effect size for this study is smaller than that observed in the pilot.22 A sample size 
of 116 with equal group split ensures 80% power at 5% significance to detect the significant 
efficacy of THR versus the BA control using a linear mixed effects model when the effect 




Of the 144 potential participants screened, 127 (88%) met study inclusion criteria and were 
enrolled in the trial and randomized (see Figure 1). The two randomized groups did not 
differ at baseline (see Table 1). After the intervention was initiated, four participants 
dropped from the THR group and seven participants dropped from the BA control group. 
There were no significant demographic differences between the two groups for dropped 
participants. One THR and two BA participants reported initiation or discontinuation of 
medications during the intervention phase.
THR Intervention Fidelity—The average fidelity rating for the eight intervention 
components were as follows: volunteers were quiet and attentive to instructor and rider 
(98.2%); lesson schedule followed (100.0%); picture schedule used (90.6%); minimal 
environmental disruptions (90.6%); instructors provided specific praise to participants 
(98.9%); instructors maintained calm demeanor (100.0%); visual cues used for directions 
(100.0%); volunteers were informed of lesson focus and rider needs (98.9%). Eighty-three 
percent of THR participants rode the same horse for the full 10-week session.
Clinical Outcomes
Table 2 shows the efficacy of the THR intervention compared to the BA control group for 
the primary and secondary outcome variables.
Self-Regulation (ABC-C)36—Participants in the THR group had significantly more 
improvements from baseline to post-intervention on the ABC-C Irritability subscale score 
with an effect size of 0.50 (p=.02). The analysis of the ABC-C weekly data indicated that the 
two groups were significantly different in the change from baseline beginning by the fifth 
week of the intervention (Figure 2).
Similarly, participants in the THR group showed significantly more improvements in the 
ABC-C Hyperactivity subscale score with an effect size of 0.53 (p=.01). The time course of 
the weekly profile of Hyperactivity subscale had a similar pattern as the Irritability subscale 
Gabriels et al. Page 7













with significantly greater improvement in THR group starting at week 5. There was no 
significant difference between the two groups on the other ABC-C subscales.
Social Measure (SRS)47—The THR group had a greater improvement on the Social 
Cognition and Communication subscales of the SRS as compared to the BA control group 
with effect sizes of 0.41 (p=.05) and 0.63 (p=.003). There was no significant difference 
between groups on the other subscales of the SRS.
Communication (SALT)40—Although participants in the THR group spoke fewer words 
at the pre-intervention language assessment, this was not significantly different from the BA 
control group. However, following the intervention phase, the THR group had a significant 
increase in the use of different words with an effect size of 0.54 (p=.01) and spoke more 
words with an effect size of 0.54 (p=.01) post-intervention compared to the BA control 
group.
Other Secondary Outcomes—No statistically significant between-group differences 
were found with respect to the rest of secondary outcomes, including adaptive (VABS-II)43 
and motor (BOT-2 and SIPT) behaviors,41,42 and PPVT-4.39
Sensitivity and Moderator Analyses—After adjusting for age, IQ, and gender in the 
ITT analysis, significantly greater improvements in THR group remained for Irritability 
(ES=0.51, p=.02), Hyperactivity (ES=0.53, p=.02), Social Communication (ES=0.72, p=.
002), number of words spoken, and number of new words (ES=0.52, p=.02), while 
marginally significant improvement was observed for Social Cognition score (ES=0.52, p=.
06). In per-protocol (PP) analysis of participants completing 80% of the intervention (n=52 
THR, n=48 BA control), greater improvement in the THR group was also observed for 
Irritability (ES=0.42, p=.05), Hyperactivity (ES=0.45, p=.04), Social Cognition (ES=0.33, 
p=.11), Social Communication (ES=0.57, p=.08), number of words spoken (ES=0.55, p=.
009), and number of new words (ES=0.56, p=.009), leading to similar conclusions as the 
primary ITT analysis. No significant moderation effect was found for age, IQ or gender. Of 
note, co-morbid diagnoses at study entry were obtained by caregiver report and not 
independently confirmed; therefore, these data were not included in the moderator analyses.
DISCUSSION
This article reports results from a randomized control study of 116 participants diagnosed 
with ASD (ages 6–16 years) involved in a 10-week THR intervention compared to an 
activity control group that had no interaction with horses. Results show significant post-
intervention improvements in the THR group compared to the BA control on the Irritability 
and Hyperactivity subscales of the ABC-C36 beginning by the fifth week of intervention. 
This finding replicates our pilot study.22 Compared to the BA control, the THR group also 
showed significant improvements on the SRS47 Social Cognition and Communication 
subscales along with significant improvements in the amount of words and different words 
spoken during a standard language. The outcomes of this study lend support to findings from 
previous EAAT studies with the ASD population, suggesting that there is an important 
Gabriels et al. Page 8













active ingredient in the human-equine interaction that can affect positive changes in 
irritability, hyperactivity, social, and communication behaviors in this population.
Results generate hypotheses regarding the role of the human-equine interaction requiring 
further investigation. One hypothesis is that riding and working together with the horse to 
engage in therapeutic riding activities involves a nonverbal joint-attention or shared 
attention experience that may serve a platform for improving behaviors and social-
communication skills in children with ASD. This nonverbal communication between the 
horse and the rider may include the fact that horses constantly mirror and respond to the 
rider’s body language.50 Also, this shared attention experience may be enhanced by the 
enormity of the horse combined with the task demand for the rider of maintaining bilateral 
control and balance. Outcome measures of joint attention skills, including semi-structured 
play assessments and behavioral observation coding, may be useful considerations for future 
THR studies. A second hypothesis is that the human-equine experience (i.e., warmth of the 
horse’s body and rhythmic movement of riding the horse) promotes a relaxing context, 
which may have a calming effect on children with ASD. The impact of THR on reducing 
stress levels can be explored using objective behavioral observation measures combined 
with biological measures such as galvanic skin response or salivary cortisol.50 Physiological 
measures may provide more accurate assessments of the stress levels in the ASD population, 
as gathering self-report accounts are challenging in this population.
The study is limited by the fact that several outcomes (i.e., ABC-C, SRS, VABS-II) were 
measured using non-blinded caregiver report measures, which is a unique confound to this 
type of intervention research and raises questions as to whether knowledge produced a 
placebo effect. An additional limitation is the lack of objective observational measures, 
which are needed to gain further insight into the mechanisms of behavioral changes 
observed in this study. This study also used broad measures of motor coordination, which 
limited the ability to detect possible motor-related changes. In order to have a 
comprehensive assessment of the THR intervention, a study with a placebo group (i.e. no 
intervention at all) in addition to the BA control group will provide a better insight into the 
effect of THR. Additional future study considerations include expanding demographic 
measures to include, for example, a broader measure of intellectual functioning. Finally, no 
adjustment was made for multiple secondary outcome comparisons in the analysis, as this 
may have increased the type I error rate. Therefore, caution needs to be taken into account 
when interpreting the secondary outcome results.
This study further establishes the evidence base supporting EAAT as a viable therapeutic 
option for children and adolescents with ASD. Further research is warranted to examine if 
the joint attention and movement experiences are key THR mechanisms to observe 
behavioral and social-communication improvements in the ASD population.
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Therapeutic horseback riding (THR) and autism spectrum disorder (ASD): participant 
flowchart. Note: ADOS = Autism Diagnostic Observation Schedule; BA = barn activity; 
ITT = intent to treat. a Eligible for ITT analysis; b Eligible for per protocol analysis.
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Time course of Aberrant Behavior Checklist-Community (ABC-C) subscale scores during 
the course of the 10-week therapeutic horseback riding (THR) intervention. Note: SEM = 
standard error of the mean.
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Table 1
Characteristics of Participants Who Completed the Study
Characteristic THR BA Control Total p Valuea
Participants, n 58 58 116
Age, mean (SD), years 10.5 (3.2) 10.0 (2.7) 10.2 (3.0) 0.34
Gender, M/F (counts) 49/9 52/6 101/15 0.58
IQ, mean (SD) 86.7 (25.5) 86.1 (22.7) 86.4 (24.0) 0.89
Repetitive behavior scale total score, mean (SD) 38.0 (20.9) 38.1 (19.8) 38.0 (20.2) 0.98
Community psychiatric diagnoses, % 48.3 48.3 48.3 1.0
 Mood disorder 13.8 20.7 17.2 0.32
 Anxiety disorder 27.6 15.5 21.6 0.11
 ADHD 29.3 27.6 28.4 0.84
 Learning disability 5.2 1.7 3.4 1.0
Current seizure disorder 1.7 3.4 2.6 0.56
Psychotropic medicine 46.6 50.0 48.3 0.71
Distance traveled to riding center, mean (SD) 30.8 (19.1) 27.0 (18.7) 28.9 (18.9) 0.28
Latino/Hispanic 10 11 21 0.77
Race 0.29
 American Indian or Alaska native 0 3 3
 Asian 2 2 4
 Black or African American 1 0 1
 Hawaiian/Pacific Islander 0 1 1
 Caucasian 47 45 92
 Multiracial 5 2 7
 Other 1 4 5
 Missing data 2 1 3
Note: ADHD = attention-deficit/hyperactivity disorder; BA = barn activity; F = female; M = male; THR = therapeutic horseback riding.
a
Two-tailed p value from two sample t-test, chi square test, or Fisher’s exact test, as appropriate.
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